Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2000
09/21/2000WO2000054762A2 Use of cross linked polysaccharides for the inhibition of angiogenesis
09/21/2000WO2000054759A2 Lxr modulators
09/21/2000WO2000054750A1 Method for correcting disturbance in collagen synthesis and biologically active substance for realising the same
09/21/2000WO2000054729A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2000WO2000040716A3 Soluble receptor br43x2 and methods of using them for therapy
09/21/2000WO2000040225A3 Inhibition of tnf activity
09/21/2000WO2000039077A3 Thyroid receptor ligands
09/21/2000WO2000027868A3 Connective tissue growth factor (ctgf) and methods of use
09/21/2000WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization
09/21/2000CA2675416A1 Lipoxin compounds and their use
09/21/2000CA2368148A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368122A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368068A1 27 human secreted proteins
09/21/2000CA2367895A1 Compounds and methods for modulation of estrogen receptors
09/21/2000CA2367595A1 Lxr modulators
09/21/2000CA2367461A1 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2000CA2367354A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents
09/21/2000CA2367352A1 Amine derivatives as protease inhibitors
09/21/2000CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000CA2367247A1 Compositions and methods of use of ldl-like receptor ligands for the treatment of cancer and angiogenic-based disease
09/21/2000CA2367213A1 Novel antiangiogenic peptides
09/21/2000CA2365767A1 Angiogenesis inhibition
09/21/2000CA2365655A1 Retrovirus producting cells utilizing a high multiplicity of transduction
09/21/2000CA2365214A1 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000CA2364739A1 Regulators of intracellular phosphorylation
09/21/2000CA2364637A1 50 human secreted proteins
09/21/2000CA2364635A1 47 human secreted proteins
09/21/2000CA2361819A1 Amide derivatives
09/21/2000CA2361503A1 Corticosteroid formulation
09/21/2000CA2361277A1 49 human secreted proteins
09/21/2000CA2332767A1 Dhea composition and method
09/20/2000EP1036191A2 Method for identifying ihbitors of g-protein coupled receptor hibef51
09/20/2000EP1036163A1 Differentiation of adipose stromal cells into osteoblasts and uses thereof
09/20/2000EP1036075A1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties
09/20/2000EP1036062A1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
09/20/2000EP1036059A1 Adamantane derivatives
09/20/2000EP1036058A1 Adamantane derivatives
09/20/2000EP1035853A1 Use of f prostanoid receptor agonists for treating a bone disorder
09/20/2000EP1035848A1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels
09/20/2000EP1035824A1 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
09/20/2000EP0672057B1 Analogs of pth
09/20/2000CN1267306A Cyclopeptide derivs. as adhesion inhibitors
09/20/2000CN1267296A Barbituric acid derivs with antimetastatic and antitumor activity
09/20/2000CN1266704A Medicine for treating rheumatoid arthritis and preparing process thereof
09/20/2000CN1266700A Powdered bone-setting medicine
09/20/2000CN1266697A Application of red koji and its extract in preparing medicine or health-care food
09/20/2000CN1266696A Chinese medicine for making lumbus stronger and consolidating vital energy of kidney
09/20/2000CN1056527C Tincture for anti-inflammation and stopping pain
09/20/2000CN1056525C Powder medicine composition for quick growth and bone-setting
09/19/2000US6121319 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
09/19/2000US6121312 Cyclic ether vitamin D3 compounds and uses thereof
09/19/2000US6121293 Benzothiophene compounds, compositions, and methods
09/19/2000US6121279 Phosphodiesterase inhibitor for treating respiratory system disorders
09/19/2000US6121272 Bidentate metalloprotease inhibitors
09/19/2000US6121258 For treatment of arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease
09/19/2000US6121253 Prostaglandin conjugates for treating or preventing bone disease
09/14/2000WO2000053742A2 Polynucleotides and proteins encoded thereby
09/14/2000WO2000053635A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
09/14/2000WO2000053605A1 Tyrosine kinase inhibitors
09/14/2000WO2000053600A1 Novel piperidine derivatives
09/14/2000WO2000053592A1 Osteogenesis promoters
09/14/2000WO2000053562A1 Retinoid antagonists and use thereof
09/14/2000WO2000053223A1 Apoptosis inducing molecule ii and methods of use
09/14/2000WO2000053194A1 Remedies for joint diseases
09/14/2000WO2000053157A1 Improved powdery pharmaceutical compositions for inhalation
09/14/2000WO2000044722A8 Chondrongenesis promotors and indolin-2-one derivatives
09/14/2000WO2000031263A3 Gtpase associated proteins
09/14/2000WO2000026395A3 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
09/14/2000WO2000013709A3 Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors
09/14/2000CA2367315A1 Apoptosis inducing molecule ii and methods of use
09/14/2000CA2366644A1 Tyrosine kinase inhibitors
09/14/2000CA2365230A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
09/14/2000CA2362422A1 Polynucleotides and proteins encoded thereby
09/13/2000EP1034164A1 Substituted beta-alanine derivatives as cell adhesion inhibitors
09/13/2000EP1034163A1 New cysteine derivatives, processes for their production, and pharmaceuticals containing them
09/13/2000EP1034162A1 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
09/13/2000EP1033910A1 Dipeptide apoptosis inhibitors and the use thereof
09/13/2000EP0723439B1 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women
09/13/2000CN1265918A A powder medicine and preparation process thereof
09/13/2000CN1265896A Capsule for treating arthritis and strengthening physique
09/13/2000CN1056311C Pill for waist strengthening and anti-protrusion
09/13/2000CN1056306C Plaster for treating traumatic injury and preparation process thereof
09/13/2000CN1056299C External medicine for treating rheumatic and rheumatoid arthritis
09/13/2000CN1056293C Traditional Chinese medicine Luhongdan for treating bone injury
09/13/2000CN1056290C Process for preparation of osteoproliferation treating liquid
09/12/2000US6117998 A1 adenosine receptor antagonists
09/12/2000US6117870 Cyclic amide derivatives
09/12/2000US6117839 For increasing bone growth in mammals
09/12/2000US6117654 Nucleotide sequence coding antiinflammatroy proteins; antiarthritic agents; antiinflammatory agents; bronchodilator agents
09/08/2000WO2000052210A2 Methods for targeting rna molecules
09/08/2000WO2000052186A1 Means and methods for fibroblast-like or macrophage-like cell transduction
09/08/2000WO2000052145A2 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
09/08/2000WO2000052051A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
09/08/2000WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b)
09/08/2000WO2000051983A1 N-SUBSTITUTED BENzOYL INDOLES AS ESTROGENIC AGENTS
09/08/2000WO2000051979A1 C16 unsaturated fp-selective prostaglandins analogs
09/08/2000WO2000051975A1 Alkenyl- and alkynyl-containing metalloprotease inhibitors
09/08/2000WO2000051971A1 Oxamic acids and derivatives as thyroid receptor ligands
09/08/2000WO2000051968A1 Method for the preparation of a chiral-beta-amino ester
09/08/2000WO2000051686A1 Use of integrin antagonist and a chemotherapeutic agent in the treatment of neoplasia
1 ... 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 ... 820